Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis PatientsUnknown
NCT05596526Phase 4Updated Apr 10, 2024
Sponsor: Prof Patrice Lalive
Shingles · Zoster
Switzerland
B Cell Differentiation in MSCompleted
NCT03744351NAUpdated Apr 10, 2024
Sponsor: Rennes University Hospital
Multiple Sclerosis
France
Orofacial Pain in Multiple SclerosisWithdrawn
NCT06021561N/AUpdated Apr 9, 2024
Sponsor: Varazdin General Hospital
Multiple Sclerosis
Croatia
Tysabri Observational ProgramCompleted
NCT00493298N/AUpdated Apr 8, 2024
Sponsor: Biogen
Relapsing-Remitting Multiple Sclerosis
Argentina, Australia, Belgium, Brazil, Canada +13 more
DECISIve - DiagnosE Using the Central veIn SIgn v1.0Completed
NCT05533905N/AUpdated Mar 29, 2024
Sponsor: Nottingham University Hospitals NHS Trust
Multiple Sclerosis
United Kingdom
Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)Unknown
NCT04121065N/AUpdated Mar 29, 2024
Sponsor: Neuromed IRCCS
Relapsing Multiple Sclerosis
Italy
miR-142-3p as Potential Biomarker of Synaptopathy in MSUnknown
NCT03999788NAUpdated Mar 29, 2024
Sponsor: Neuromed IRCCS
Multiple Sclerosis · Spasticity
Italy
Time Restricted Eating Outcomes in Multiple SclerosisCompleted
NCT04389970NAUpdated Mar 27, 2024
Sponsor: University of Alabama at Birmingham
Multiple Sclerosis · Diet, Healthy
United States
A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple SclerosisWithdrawn
NCT06104683Phase 2Updated Mar 27, 2024
Sponsor: Loxo Oncology, Inc.
Relapsing Multiple Sclerosis · Multiple Sclerosis
United States, Puerto Rico
A Reeducation Program to Effort to Improve the Walking of Multiple Sclerosis PatientsTerminated
NCT02874677NAUpdated Mar 26, 2024
Sponsor: Lille Catholic University
Multiple Sclerosis
France
A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple SclerosisCompleted
NCT02545868Phase 3Updated Mar 26, 2024
Sponsor: Hoffmann-La Roche
Multiple Sclerosis, Relapsing-Remitting
United States, Canada
Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis CriterionCompleted
NCT02043964NAUpdated Mar 26, 2024
Sponsor: Lille Catholic University
Clinically Isolated Syndrome · Multiple Sclerosis
France
Therapeutic Adherence of Multiple Sclerosis PatientsUnknown
NCT04837352N/AUpdated Mar 26, 2024
Sponsor: Lille Catholic University
Multiple Sclerosis
France
Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple SclerosisNot Yet Recruiting
NCT06330077Phase 2Updated Mar 26, 2024
Sponsor: Assistance Publique - Hôpitaux de Paris
Multiple Sclerosis · Remitting Relapsing Multiple Sclerosis
France
Trunk Control and Disability in Persons With Multiple SclerosisCompleted
NCT06327789N/AUpdated Mar 25, 2024
Sponsor: Zonguldak Bulent Ecevit University
Multiple Sclerosis
Turkey (Türkiye)
A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple SclerosisCompleted
NCT05334472N/AUpdated Mar 25, 2024
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States
Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple SclerosisUnknown
NCT06329414N/AUpdated Mar 25, 2024
Sponsor: University of Utah
Multiple Sclerosis · Major Depressive Disorder · Treatment Resistant Depression
United States
the EXPOSITION StudyUnknown
NCT06325358N/AUpdated Mar 22, 2024
Sponsor: University of Pavia
Multiple Sclerosis, Relapsing-Remitting · Environmental Exposure · Lifestyle Factors
Italy
Assessing the Role of Mitochondrial Dysfunction in Primary Progressive Multiple SclerosisUnknown
NCT06025903N/AUpdated Mar 22, 2024
Sponsor: IRCCS San Raffaele
Multiple Sclerosis
Italy
Tele-Assessment and Face-to-Face Evaluation of Balance in MSCompleted
NCT04743284N/AUpdated Mar 21, 2024
Sponsor: Istanbul University - Cerrahpasa
Multiple Sclerosis
Turkey (Türkiye)
Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone DiseaseUnknown
NCT06320444N/AUpdated Mar 20, 2024
Sponsor: University of Dublin, Trinity College
Motor Neuron Disease, Amyotrophic Lateral Sclerosis · Motor Neuron Disease Progressive Spinal Muscle Atrophy · Primary Lateral Sclerosis · Multiple Sclerosis
Ireland
Social and Moral Cognition in Multiple SclerosisUnknown
NCT06318923NAUpdated Mar 20, 2024
Sponsor: Lille Catholic University
Multiple Sclerosis
France
COld Exposure With Controlled BReathing And Meditation in Patients With Multiple Sclerosis (COBRAMS)Unknown
NCT06280573NAUpdated Mar 19, 2024
Sponsor: Comenius University
Multiple Sclerosis
Slovakia
Tysabri Observational Cohort Study - Multiple Sclerosis (MS) RegistriesCompleted
NCT03399981N/AUpdated Mar 19, 2024
Sponsor: Biogen
Progressive Multifocal Leukoencephalopathy
United States
Transcutaneous Posterior Tibial Nerve Stimulation in Patients With Multiple Sclerosis Related Urge IncontinenceUnknown
NCT06314412NAUpdated Mar 18, 2024
Sponsor: Istituto Auxologico Italiano
Multiple Sclerosis
Italy

Previous page Next page